Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Abbott Laboratories Exceeds Expectations with Impressive Q4 2024 Earnings

January 26, 2025
Abbott Laboratories, a leading global healthcare company, has reported its fourth-quarter and full-year 2024 results, exceeding market expectations. The company's strong performance was driven by robust sales across its diversified portfolio of medical devices, diagnostics, nutrition, and pharmaceutical products.

In the fourth quarter, Abbott Laboratories posted a revenue of $12.5 billion, representing a growth of 9% compared to the same period last year. The company's net income for the quarter stood at $2.3 billion, reflecting a significant increase of 17% year-over-year. These impressive financial figures can be attributed to the continued demand for Abbott's innovative healthcare solutions worldwide.

One of the key highlights of Abbott Laboratories' Q4 2024 results was the strong performance of its cardiovascular and diabetes care segments. Both divisions witnessed double-digit growth, driven by increased adoption of the company's groundbreaking technologies and therapies. Additionally, Abbott's diagnostics segment continued to demonstrate strong growth, supported by the demand for advanced diagnostic tests amid the ongoing COVID-19 pandemic.

Looking ahead, Abbott Laboratories also issued its 2025 financial outlook, projecting continued revenue growth and profitability. The company expects its diversified product portfolio and expanding geographic presence to drive sustainable growth in the coming years.

With its solid financial performance and positive outlook, Abbott Laboratories is well-positioned to outperform healthcare stocks in 2025. Investors seeking to capitalize on the company's success are recommended to consult professionals at Stocks Prognosis for expert advice on the potential movement of Abbott Laboratories' stocks.

Disclaimer: This news does not contain any source information and does not endorse the buying or selling of Abbott Laboratories' stocks. Consult professionals at Stocks Prognosis for reliable investment forecasts.
If you want to leave a comment, then you need Login or Register





Other data for ABT

Related data

ABTJune 5, 2025Abbott Laboratories ABT is Attracting Investor Attention: Here is What You Should Know  ~1 min.

Abbott Laboratories (ABT) has been making waves in the healthcare sector, attracting attention from investors around the globe....

ABTMarch 18, 2025Abbott Laboratories Continues to Drive Growth in the Healthcare Sector  ~2 min.

Abbott Laboratories (ABT) has emerged as a top player in the healthcare industry, making it an attractive stock for long-term investors....

ABTMarch 17, 2025Abbott Laboratories: A Leader in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) is a renowned healthcare company that has caught the attention of investors and industry experts alike....

ABTMarch 16, 2025Abbott Laboratories: Breaking New Ground in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making waves in the healthcare industry with its groundbreaking innovations....

ABTMarch 15, 2025Abbott Laboratories: A Healthcare Stock With Long-Term Investment Potential  ~2 min.

Abbott Laboratories (NYSE:ABT) is a renowned healthcare company that has been delivering groundbreaking medical technologies and products for decades....

ABTFebruary 26, 2025Abbott Laboratories Continues to Deliver Strong Earnings Growth  ~2 min.

Abbott Laboratories, a leading global healthcare company, has reported steady growth in earnings over the past five years....

ABTFebruary 22, 2025Abbott Laboratories: A Rising Star in the Pharmaceutical Industry  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making significant progress in the pharmaceutical industry, positioning itself as one of the best drug stocks to buy now....

ABTFebruary 21, 2025Abbott Laboratories NYSE:ABT: A Leading Drug Stock with Promising Future  ~1 min.

Abbott Laboratories, a renowned pharmaceutical company, has emerged as one of the best drug stocks to invest in....

ABTFebruary 21, 2025ABBOTT LABORATORIES Stock Hits Price Target with 16.11% Profit: QuantWave Forecast Success  ~2 min.

On December 2, 2024, QuantWave, the automated forecasting platform, issued a long signal for ABBOTT LABORATORIES stock when it was trading at 115.66 $....

ABTFebruary 20, 2025ABBOTT LABORATORIES Stock Hits Price Target Forecast with 17.28% Profit  ~2 min.

Abbott Laboratories (ABT) has recently achieved its price target forecast of 132.56 $, signaling a successful long trade with a profit of 17.28%....

ABTFebruary 22, 2025Abbott Laboratories: A Rising Star in the Pharmaceutical Industry  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making significant progress in the pharmaceutical industry, positioning itself as one of the best drug stocks to buy now....

ABTDecember 9, 2024Abbott Laboratories: Revolutionizing Healthcare with Innovative Solutions  ~2 min.

Abbott Laboratories (ABT) is making waves in the healthcare industry with its groundbreaking innovations and commitment to improving lives....

ABTJanuary 2, 2025Abbott Laboratories: A Promising Stock with Strong Fundamentals  ~2 min.

Abbott Laboratories (NYSE:ABT) is catching the attention of investors, including Diamond Hill Capital, as one of their top stock picks....

ABTMarch 15, 2025Abbott Laboratories: A Healthcare Stock With Long-Term Investment Potential  ~2 min.

Abbott Laboratories (NYSE:ABT) is a renowned healthcare company that has been delivering groundbreaking medical technologies and products for decades....

ABTJanuary 1, 2025Abbott Laboratories: A Diamond in the Healthcare Sector  ~1 min.

Diamond Hill Capital, a prominent investment firm, has recently revealed Abbott Laboratories (NYSE:ABT) as one of their top stock picks....